BLB Solicitors - The Leading Chronic Pain & CRPS Solicitors
BLB Solicitors - The Leading Chronic Pain & CRPS Solicitors
  • Home
  • Chronic Pain Claims
    • CRPS Compensation
    • Fibromyalgia Compensation
    • Myofascial Pain Syndrome Compensation
    • Somatic Symptom Disorder Compensation
    • Neuropathic Pain Compensation
    • Functional Neurological Disorder Compensation
    • Chronic Pain Syndrome Compensation
  • Case Studies
  • Chronic Pain Blog
  • Testimonials
  • Contact Us

Home » Pregabalin (Lyrica) linked to rise in deaths

Chronic Pain Sep 11th, 2017
Pregabalin

Pregabalin (Lyrica) linked to rise in deaths

A BBC report today suggests that pregabalin, which is also marketed as Lyrica, has been linked to a rise in deaths.

Pregabalin forms part of the daily medication regime for many people suffering chronic pain. Increasingly, however, it seems that it is becoming the drug of choice for many people addicted to other drugs.

Previously costing the NHS around £100 for a month’s supply, that cost has reduced in recent years to around £4 per month and this lower cost has resulted in far more being prescribed. And therein lies the problem because, according to the report, the major source of ‘black market’ pregabalin are people to whom it has been legitimately prescribed.

In conjunction with other drugs, particularly heroin, pregabalin can slow the heart rate and is a respiratory suppressant. Last year it was linked to 111 deaths in the UK.

What works for one…

It is rare to find two people suffering chronic pain who take the same daily cocktail of medication. That is because what works for one, may not work for another. Indeed, it is usually a case of trial and error to find the type and balance of medication that works for the individual.

A very common example that I see among our clients is the case of pregabalin versus gabapentin. They are similar drugs to the extent that they are both used in the treatment of epilepsy as well as neuropathic pain. However, whether somebody is taking pregabalin or gabapentin, it is not unusual to find that they have previously tried the other and, for a variety of reasons, it has either not worked for, or not agreed with, them.

Accordingly, if somebody suffering chronic pain is prescribed pregabalin, it usually means that it has proved effective for them and has consequently become a vital constituent in their daily pain arsenal.

The fear

Whilst clearly a very worrying problem, it would be deeply regrettable if today’s BBC report and the inevitable press and political reaction to it, serves ultimately to force people for whom pregabalin has proved effective to have to fight to maintain themselves on their medication.

Further and more generally, my fear is that whilst pregabalin is not an opioid, such stories of its misuse will only further fuel the growing war on painkillers in the UK, which serves only to harm all those suffering chronic pain.

You may also be interested in the following articles:

Employment issues for those suffering CRPS and Chronic Pain

Chronic Pain linked to increased risk of Dementia

A beginner’s guide to Mindfulness for CRPS and Chronic Pain

Can symptoms of CRPS be remitted using low-dose Naltrexone?

Who is likely to develop CRPS?

Richard Lowes
Make an Enquiry

Contact Us

Contact Form

Left Column

Right Column

Centre

 
Sending

Recent Articles

  • The law on accessible toilets
  • Taking medication abroad
  • CRPS and excessive sweating
  • The importance of medical records in your CRPS compensation claim
  • CRPS and sleep

Share this Article

Newsletter Sign-up

* indicates required

Legal Glossary

Find Out More

You may also like...

  • Sep 2nd, 2017
    Folic Acid and Vitamin B12 can improve the symptoms of Fibromyalgia and CFS
    Read Article
  • Sep 12th, 2017
    Are chronic pain sufferers exposed to a medication time bomb?
    Read Article
View All Related Articles

Get in Touch Today

Contact Form

Left Column

Right Column

Centre

 
Sending

1 Edgar Buildings,
George Street,
Bath, BA1 2DU

01225 462871 01225 445060
Authorised & Regulated by Solicitors Regulation Authority (No. 636644).
©2025 BLB Solicitors  |  Privacy & Terms